Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
The DOI matches its Crossref record.
Abstract
In Alzheimers's disease (AD) a disturbed balance between synthesis and removal of Aβ leads to the formation of Aβ deposits and a reaction of the innate immune system. Little evidence exists for a contribution of the adaptive immune response in AD, as no signs of influx of blood borne cells or presence of immunoglobulins in Aβ deposits are apparent. Factors of the complement(C) system and pentraxins act as pattern recognition molecules and mediate uptake of Aβ by glial cells expressing C-receptors (Crec). These interactions may, however, also lead to synthesis and secretion of reactive oxygen species (ROS), cytokines, chemokines and other potentially neurotoxic agents by the glial cells. Virtually all complement factors are produced in brain, and the expression is increased in AD affected brain areas. In AD brain areas with amyloid deposits especially classical pathway C activation products are readily observed. Also C regulatory proteins (Creg) and Crec can be found in the brain parenchyma and are upregulated, especially under acute inflammatory conditions, such as meningitis. However, under chronic low-grade inflammatory conditions, such as in AD, Creg and to some extent Crec expression may remain at a low level, thereby allowing C activation to proceed, leading to sustained activation of glial cells and neurodegenerative changes. In this review evidence from immunohistochemical, in vitro and animal studies pointing to a role for C activation is discussed, with special focus on the disturbed balance between C activators and Cregs in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactive microglia (8, 9, 11, 12)”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [11]
In the citing paper
“Deficits have been found in the expression of the innate immune-repressor complement factor H (CFH) associated with significant increases of Aβ42 peptides in brains and retinas of transgenic models of AD (Veerhuis, 2011).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Veerhuis, 2011
Citations
Cites
Still being checked.
Cited by
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactivemicroglia (8, 9, 11, 12) and in the brains of AD amyloidosis mouse models (10, 17, 31).”
BackgroundThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
“Deficits have been found in the expression of the innate immune-repressor complement factor H (CFH) associated with significant increases of Aβ42 peptides in brains and retinas of transgenic models of AD (Veerhuis, 2011).”
BackgroundVeerhuis, R., Nielsen, H. M., & Tenner, A. J. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.003 · Cited by 419
Self-citationZhan, X., Stamova, B., & Sharp, F. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00042 · Cited by 351
Streit, W. J., Xue, Q.-S., Tischer, J., & Bechmann, I. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0142-6 · Cited by 317
“A major discrepancy between microglial activation in vitro and in vivo is that in vitro experiments use the proverbial sledgehammer method (LPS or similar) to achieve maximal microglial stimulation in vitro, producing maximal and readily measurable effects, while at the same time it is recognized that the intensity of…”
Method
Metadata
- Authors
- Veerhuis, R.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Veerhuis, Robert
- ORCID
- Veerhuis, Robert
- Venue
- Current Alzheimer Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-02-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-58
- ISSN
- 1567-2050 (ISSN-L)
- OpenAlex
- W2091347484
- Cited by
- 80
- References
- 0
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 15
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Alzheimer Research (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, complement system, neuroinflammation, amyloid-beta, classical complement pathway, glial cells, reactive oxygen species, pentraxins, innate immunity, low-grade inflammation, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Central Nervous System, Complement System Proteins, Gene Expression Regulation, Humans, Inflammation, Models, Biological, Receptors, Complement, Signal Transduction, Antigens, CD, Proteomics, Genome-Wide Association Study, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD. https://app.cochat.ai/papers/10.2174/156720511794604589
- The paper
- Veerhuis, R. (2011). Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD. Current Alzheimer Research. https://doi.org/10.2174/156720511794604589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.